Nagarajan Chandramouli

Title: Innovations of Nagarajan Chandramouli

Introduction

Nagarajan Chandramouli is a notable inventor based in Morristown, NJ (US). He has made significant contributions to the field of pharmacology through his innovative work on somatostatin peptides. His research focuses on developing analogues that exhibit interesting pharmacological properties.

Latest Patents

Nagarajan holds a patent for somatostatin analogues comprising a specific amino acid sequence. The formula includes -(D/L)Trp-Lys-X,-X,, where X represents a substituted Thr, Ser, Tyr, Glu, or Cys residue. The second X is an α-amino acid with an aromatic residue on the C side chain, or an amino acid unit selected from Dab, Dpr, Dpm, His (Bzl)HyPro, thienyl-Ala, cyclohexyl-Ala, and t-butyl-Ala. The residue Lys corresponds to the native somatostatin-14, and these compounds can exist in free form, salt form, or complexed with a detectable element. This patent highlights his innovative approach to enhancing pharmacological applications.

Career Highlights

Nagarajan is currently employed at Novartis AG, where he continues to advance his research in pharmacology. His work has garnered attention for its potential therapeutic applications, particularly in the field of peptide-based treatments.

Collaborations

Nagarajan has collaborated with esteemed colleagues, including Rainer Albert and Wilfried Bauer. These partnerships have contributed to the success of his research and the development of his patented innovations.

Conclusion

Nagarajan Chandramouli's contributions to the field of pharmacology through his innovative work on somatostatin peptides demonstrate his commitment to advancing medical science. His patent reflects a significant step forward in the development of therapeutic agents.